Sterne, J.A.C., Diaz, J., Villar, J., et al. (2020) Corticosteroid Therapy for Critically Ill Patients with COVID-19: A Structured Summary of a Study Protocol for a Prospective Meta-Analysis of Randomized Trials. BMC, 21, Article No. 734.
https://doi.org/10.1186/s13063-020-04641-3

has been cited by the following article:

• TITLE: COVID-19 and the Vascular Elderly Subject: Illustration of Therapeutic Management with Corticosteroids in an Elderly Diabetic Patient with COVID-19

  AUTHORS: Ibrahima Amadou Dembele, Abrar-Ahmad Zulfiqar, Romuald Nounga Nyanke, Sékou Landoure, Stéphane Loique Djeugoue, Adama Sinayoko, Nouhoum Kone, Paul Antoni, Amadou Nouroudine, Rosunee Ahsveen, Yacouba Koné, Aoua Diarra, Tania Mekuiko Ngeupi, Mamadou Cissoko, Mamadou Mallé, Keïta Kaly, Djibril Sy, Djénébou Traoré, Didier Mukéba Tshialala, Assétou Soukho Kaya, Emmanuel Andres

  KEYWORDS: COVID-19, Diabetes Mellitus, Elderly person, Corticosteroids, Internal Medicine

  JOURNAL NAME: Open Journal of Clinical Diagnostics, Vol.14 No.1, March 29, 2024

  ABSTRACT: Introduction: The severity of Sars-Cov-2 infection is associated with the development of acute respiratory distress syndrome (ARDS). The progression to ARDS appears to be driven by a major inflammatory mechanism potentially sensitive to corticosteroids. Observation: This article describes the case of an elderly patient was admitted to emergency departments for intense asthenia, accompanied by motor diarrhoea, dyspnoea with desaturation in ambient air, in a context of strong suspicion of infection linked to COVID-19. The article also reviews the existing literature on the diagnosis and treatment of this severe form of the disease. Conclusion: Corticosteroids, and in particular dexamethasone, have been shown to be effective in the management of patients with COVID-19, an oxygen-releasing disease.